Alder BioPharmaceuticals, Inc. named Robert W. Azelby president and chief executive officer of Alder, effective June 13, 2018. He also will serve on the company's board of directors. Mr. Azelby joins Alder from Juno Therapeutics, Inc., where he served as executive vice president and chief commercial officer. He succeeds Paul B. Cleveland, who has been acting as Alder's interim president and chief executive officer.

Mr. Cleveland will continue to serve on the company's board of directors.